{
  "id": 17106725,
  "title": "Pancreatic cancer: The RAS paradigm shift",
  "url": "https://urgent.news/2026/10/29/pancreatic-cancer-the-ras-paradigm-shift",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-29T14:00:00.000Z",
  "source": {
    "name": "PLOS Medicine",
    "slug": "plos-medicine",
    "url": "https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1005283"
  },
  "original_language": "en",
  "account": null,
  "summary": "by Samuel P. Soff, Eileen M. O’Reilly Treatment approaches for pancreatic adenocarcinoma, an aggressive disease with poor prognosis, are evolving beyond cytotoxic chemotherapy. Recent advances in RAS targeting with small molecules are redefining therapeutic paradigms. Treatment approaches for pancreatic adenocarcinoma, an aggressive disease with poor prognosis, are evolving beyond cytotoxic…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}